DE602005009161D1 - Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese - Google Patents

Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese

Info

Publication number
DE602005009161D1
DE602005009161D1 DE602005009161T DE602005009161T DE602005009161D1 DE 602005009161 D1 DE602005009161 D1 DE 602005009161D1 DE 602005009161 T DE602005009161 T DE 602005009161T DE 602005009161 T DE602005009161 T DE 602005009161T DE 602005009161 D1 DE602005009161 D1 DE 602005009161D1
Authority
DE
Germany
Prior art keywords
phospholanes
chirogenic
asymmetric synthesis
chromium
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005009161T
Other languages
English (en)
Inventor
Garett Stewart Hoge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE602005009161D1 publication Critical patent/DE602005009161D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65685Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine oxide or thioxide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/10Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65683Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602005009161T 2004-04-01 2005-03-23 Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese Expired - Fee Related DE602005009161D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55904304P 2004-04-01 2004-04-01
PCT/IB2005/000768 WO2005095424A1 (en) 2004-04-01 2005-03-23 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis

Publications (1)

Publication Number Publication Date
DE602005009161D1 true DE602005009161D1 (de) 2008-10-02

Family

ID=34962295

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009161T Expired - Fee Related DE602005009161D1 (de) 2004-04-01 2005-03-23 Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese

Country Status (9)

Country Link
US (1) US7390931B2 (de)
EP (1) EP1735324B1 (de)
JP (1) JP2007530657A (de)
AT (1) ATE405572T1 (de)
BR (1) BRPI0508998A (de)
CA (1) CA2561755A1 (de)
DE (1) DE602005009161D1 (de)
ES (1) ES2309731T3 (de)
WO (1) WO2005095424A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE41920E1 (en) 1996-07-24 2010-11-09 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
CA2603129A1 (en) * 2005-04-06 2006-10-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
CA2603215A1 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
MX2007014129A (es) * 2005-05-10 2008-01-11 Teva Pharma Resolucion optica del acido 3-carbamoilmetil-5-metil hexanoico.
ATE486841T1 (de) * 2005-05-10 2010-11-15 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
WO2006122255A1 (en) 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabalin free of isobutylglutaric acid and a process for preparation thereof
KR20080034205A (ko) 2005-09-19 2008-04-18 테바 파마슈티컬 인더스트리즈 리미티드 (s)-프레가발린의 신규한 합성을 위한 주요 중간체인 키랄3-카르바모일메틸-5-메틸 헥산산
CA2646474A1 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 3-isobutylglutaric acid
TW200815323A (en) * 2006-05-24 2008-04-01 Teva Pharma Processes for the preparation of R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof
WO2007143113A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. The use of enzymatic resolution for the preparation of intermediates of pregabalin
EP1912931A2 (de) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. (s)-prägabalin-nitril-präparat
BRPI0803092A2 (pt) * 2007-03-22 2011-08-30 Teva Pharma sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina
WO2009046309A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
EP2116618A1 (de) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnose und Behandlung des Kawasaki-Syndroms
US20100087525A1 (en) * 2008-06-23 2010-04-08 Lilach Hedvati Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
CN103788133A (zh) * 2014-01-22 2014-05-14 常州大学 一种含磷五元杂环类化合物及其合成方法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
USRE41920E1 (en) * 1996-07-24 2010-11-09 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
AU9019198A (en) * 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
BR9911917A (pt) * 1998-07-09 2001-03-27 Warner Lambert Co Composições compreendendo análogos de gaba e cafeìna
NZ509231A (en) * 1998-07-09 2003-08-29 Warner Lambert Co Use of GABA analogs to treat insomnia
US6359005B1 (en) * 1998-10-16 2002-03-19 Warner-Lambert Company Method for the treatment of mania and bipolar disorder
MXPA03004168A (es) * 2000-12-13 2004-12-02 Warner Lambert Co Sintesis de ligandos bisfosfolanos p-quirales y de sus complejos con metales de transicion para uso como catalizadores de hidrogenacion asimetrica.

Also Published As

Publication number Publication date
ATE405572T1 (de) 2008-09-15
US7390931B2 (en) 2008-06-24
US20050222464A1 (en) 2005-10-06
JP2007530657A (ja) 2007-11-01
EP1735324A1 (de) 2006-12-27
WO2005095424A1 (en) 2005-10-13
CA2561755A1 (en) 2005-10-13
WO2005095424A8 (en) 2005-12-15
ES2309731T3 (es) 2008-12-16
EP1735324B1 (de) 2008-08-20
BRPI0508998A (pt) 2007-09-04

Similar Documents

Publication Publication Date Title
DE602005009161D1 (de) Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
ATE382049T1 (de) Neue 2-benzylaminodihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE551314T1 (de) Gasphasensynthese von 2,3,3,3-tetrafluor-1-propen aus 2-chlor-3,3,3-trifluor-1-propen
ATE347738T1 (de) Platin-freier elektrokatalysator
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
DE502006005581D1 (de) Ukmischungen, ein verfahren zu deren herstellung, verfahren zur herstellung von verbund-formteilen und deren verwendung
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
NO20064735L (no) Forbedret proteinekspresjonsutbytte i cellefrie proteinsyntesesystemer ved tilsats av antiskumforbindelser
DE50306845D1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
ATE485304T1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
ATE278707T1 (de) Antipicornavirale verbindungen und zusammensetzungen, ihre pharmazeutische verwendung, und materialien für ihre synthese
DE602006004911D1 (de) Gasphasenoxidationskatalysator und dessen Verwendung zur Herstellung von Acrylsäure
ATE349455T1 (de) Hydroxydiphosphine und deren verwendung in der katalyse
DE602006005898D1 (de) Verfahren zur herstellung von cyclohexanon und cyclohexanol
DE602006010365D1 (de) Verfahren zur herstellung von isocyanatosilan und silylisocyanurat
DE60133817D1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
Cheshire et al. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
ATE446299T1 (de) Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin
Kano et al. Catalytic asymmetric synthesis of cyclic α-alkyl-amino acid derivatives by C, N-double alkylation
ECSP066275A (es) Piridinilanilidas
WO2007115929A8 (de) Thiazolyl-dihydro-quinazoline
ATE442355T1 (de) Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee